STAT3 and gastric cancer: Additionally, the natural polyphenol epigallocatechin gallate (EGCG) exerts dual immunomodulatory effects by transcriptionally repressing STAT3, thereby downregulating PLXNC1 expression and reducing exosomal miR-92b-5p levels in gastric cancer cells.